Pharma, biotech, medical device, and health professionals are invited to attend the 2nd Investigator-Initiated Trials Summit on November 2-3, 2022 in Philadelphia. This summit provides an unmatched opportunity for discussions on engaging investigators, aligning research with organizational goals, designing and executing the best study protocols, and fostering collaboration.
Attendees can learn ways of managing costs and securing operational support in investigator-initiated trials. Further, attendees can learn and network at three events for the cost of just one event ticket, since their registration also gains them entry to the 6th Digital Strategy & Innovation for Medical Affairs or the 3rd Next-Gen MSL Excellence summits.
The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events.
Important topics of discussion:
- Analyze the positive impact of collaborative research
- Gather insights on negotiating IIT and collaborative research global study contracts
- Explore the challenges in regulatory and compliance sectors
- Design a strong structure to sync RWE for added value
- Arrange the requisite oversight for managing multisite trials
- Plan strategies to support IIT projects
- Determine the company and investigator’s role in externally sponsored research
An impressive lineup of speakers will participate in keynote speeches, discussions, and fireside chats, sharing ways to overcome compliance and regulatory roadblocks in trials. Hear experts offering solutions for the challenges that hinder the discovery and safe development of effective therapies.
At the summit, medical professionals and executives will discuss how to identify key elements within a contract and ways to accelerate negotiations. They will spotlight the best selection criteria for evaluating investigators and proposed IITs. Leaders will also educate the audience on the difference between company-sponsored publications and investigator-initiated publications.
The group discussions will focus on finding solutions for common issues faced in managing IIT programs, and the networking opportunities offered during this summit will help companies establish important long-term ties.
To learn more, please visit https://ibn.fm/4VuBr
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.